Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$48.3M
-8.3% from 2023
Prescriptions
15K
$3,124.02 per claim
Patients
1,883
1,817 prescribers
Total spending, 2024
$48.3M
$25,646.71 per patient
Medicare prescription drug plans paid $48.3M for Lamictal Xr in 2024, for 15,464 prescriptions and refills to 1,883 patients (down 8.3% from 2023). The average cost per claim was $3,124.02.
New York had the highest Medicare cost for Lamictal Xr in 2024: $5.1M for 1,892 claims, followed by Florida ($4.5M).
Bassel Abou-Khalil, neurology in Nashville, TN, had the highest Medicare cost for Lamictal Xr in 2024: 161 claims costing $705K.
Lamictal Xr is made by GSK plc (GSK), listed in the Medicare spending data as Glaxosmithkline.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Bassel Abou-Khalil Nashville, TN | Neurology | 161 | 19 | $705K |
| Manoj Raghavan Milwaukee, WI | Neurology | 57 | 15 | $377K |
| Stephan Eisenschenk |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 1,967 | 16,964 | 2,051 | $51.1M |
| 2023 | 1,872 | 16,023 | 1,940 | $52.7M |
| 2024 | 1,817 | 15,464 | 1,883 | $48.3M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Neurology |
| 70 |
| 12 |
| $300K |
| Jean E Cibula Gainesville, FL | Neurology | 95 | 13 | $296K |
| Trudy Pang Boston, MA | Neurology | 33 | Under 11 | $250K |
| Elizabeth A Thiele Boston, MA | Neurology | 83 | Under 11 | $244K |
| Deborah S Zielinski Chicago, IL | Nurse Practitioner | 92 | Under 11 | $237K |
| Olga Taraschenko Aurora, CO | Neurology | 84 | Under 11 | $233K |
| Christianne N Heck Los Angeles, CA | Neurology | 33 | Under 11 | $221K |
| Michael J Doherty Seattle, WA | Neurology | 54 | Under 11 | $218K |
| Hannah M Quinn Rochester, NY | Nurse Practitioner | 86 | Under 11 | $214K |
| Daniel Friedman New York, NY | Neurology | 96 | Under 11 | $207K |
| Jessica Bishop Boise, ID | Physician Assistant | 86 | Under 11 | $201K |
| Rodney A Radtke Durham, NC | Neurology | 34 | Under 11 | $188K |
| Kaarkuzhali B Krishnamurthy Boston, MA | Neurology | 20 | Under 11 | $180K |
| Eric B Geller Livingston, NJ | Neurology | 72 | Under 11 | $176K |
| Laura A Kalayjian Los Angeles, CA | Neurology | 38 | Under 11 | $176K |
| Patricia B Rogers Rochester, NY | Nurse Practitioner | 79 | Under 11 | $174K |
| Laura A Brown Gainesville, FL | Nurse Practitioner | 58 | 14 | $171K |
| Soka Yu New York, NY | Nurse Practitioner | 43 | Under 11 | $156K |
| Lucretia Long Columbus, OH | Nurse Practitioner | 49 | Under 11 | $150K |
| Tracy J Jasinski Omaha, NE | Nurse Practitioner | 51 | Under 11 | $148K |
| Heidi L Henninger Scarborough, ME | Neurology | 47 | Under 11 | $146K |
| Adithya Sivaraju New Haven, CT | Neurology | 52 | Under 11 | $137K |
| Jennifer L Hopp Baltimore, MD | Neurology | 37 | Under 11 | $136K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Glaxosmithkline GSK | 15,467 | $48.3M |